NTRK2 and breast carcinoma: Our findings uniquely demonstrate that, in anoikis resistant breast cancer cells, NF-κB transcriptional activity increases to mediate direct up-regulation of TrkB, and its ligand, NTF3 setting up an aberrant autocrine signaling loop.